Director/PDMR Shareholding

Paris, France and Camberley, UK – 11 November 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has been notified that, on 10 November 2020, Edwin Snape, a Non-Executive Director of the Company, purchased 1,080 ordinary shares of €1/15 each in the Company at a price of

Visit Page

Acquisition of IT-IS International Ltd

Deal in line with strategy, secures key IP for the Company’s rapid-PCR instruments, expands its core capabilities and product offering Paris, France and Camberley, UK – 15 October 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the acquisition of the entire share capital of IT-IS International Ltd (IT-IS),

Visit Page

RESULTS OF ANNUAL GENERAL MEETING

Paris, France and Camberley, UK – 29 September 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that its Annual General Meeting (AGM), including its ordinary and extraordinary general meetings, was held this afternoon. http://novacyt.com/wp-content/uploads/2020/09/Novacyt-AGM-results-statement-ENGLISH-29.09.2020.pdf

Visit Page